Being that this was published on Jan 16, 2016, this has got to be the most recent and most comprehensive study that I have ever seen on vaporizers. Not only that, but it was published by the US National Library of Medicine/National Institute of Health.
An excerpt from that link:
The largest difference was seen for THC vaporized from THC-type cannabis with 54.6% and 82.7% for the DaVinci Vaporizer® and the Arizer Solo®, respectively. Here, the yield differed by 50% between the device with the lowest and that with the highest vaporizing efficiency. Lowest recoveries between 48.5–58.5% for cannabinoids from cannabis were obtained with the DaVinci Vaporizer® and the Volcano Medic®, whereas the Plenty Vaporizer® released 56.1–66.8% of total cannabinoids into the vapor.
Best recoveries were obtained for the Arizer Solo® with 70.0–82.7%. The better the recovery the less drug (cannabis or cannabinoids) is needed to deliver a defined therapeutic dose to a patient. This is an economic issue in terms of cost-effectiveness of the therapy with medicinal cannabis. Another aspect is the reliable and constant release of cannabinoids into the vapor to guarantee uniformity of the dosage, reflected by the RSD values obtained for the different devices. All electrically-driven vaporizers showed small variabilities with RSD values ≤ 13%. Excellent reproducibility was found for the Plenty Vaporizer® (RSD ≤ 6.5%). It is also important to note that the design of the vaporizers had an impact on the yield of cannabinoids released with the vapor. Devices such as Volcano Medic® and Plenty Vaporizer® providing rather cold vapor for a mild, less airways-irritating inhalation revealed a smaller recovery of cannabinoids in the vapor compared to Arizer Solo®. However, this device, designed to release a maximum amount of cannabinoids into the vapor and lacking a cooling tube, produces a rather hot vapor, which may be less tolerated by patients.